American Journal of Cardiology
Volume 102, Issue 12 , Pages 1595-1601 , 15 December 2008

Thirty-Year Trends (1975–2005) in the Magnitude, Patient Characteristics, and Hospital Outcomes of Patients With Acute Myocardial Infarction Complicated by Ventricular Fibrillation

  • Robert J. Goldberg, PhD

      Affiliations

    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 508-856-3991; fax: 508-856-4596
    • ,
  • Jorge Yarzebski, MD, MPH

      Affiliations

    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts
    • ,
  • Frederick A. Spencer, MD

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Juan C. Zevallos, MD

      Affiliations

    • University of Puerto Rico, San Juan, Puerto Rico
    • ,
  • Darleen Lessard, MS

      Affiliations

    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts
    • ,
  • Joel M. Gore, MD

      Affiliations

    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts

Received 18 June 2008 ,Revised 5 August 2008 ,Accepted 5 August 2008.

References 

  1. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in the attack rates and survival rates of acute myocardial infarction (1975–1981): the Worcester Heart Attack Study. JAMA. 1986;255:2774–2779
  2. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Incidence and case fatality rates of acute myocardial infarction (1975–1984): the Worcester Heart Attack Study. Am Heart J. 1988;115:761–767
  3. Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades (1975–1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999;33:1533–1539
  4. Goldberg RJ, Spencer FA, Yarzebski J, Lessard D, Gore JM, Alpert JS, et al. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol. 2004;94:1373–1378
  5. Chiriboga D, Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: a community-wide perspective. Circulation. 1994;89:998–1003
  6. Behar S, Goldbourt U, Reicher RH, Kaplinky E Principal Investigators of the STRIAT Study. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol. 1990;66:1208–1211
  7. Volpi A, Maggioni A, Franzosi MG, Pampallona S, Mauri F, Tognoni G. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med. 1987;317:257–261
  8. Nicod P, Gilpin E, Dittrich H, Wright M, Engler R, Rittlemeyer J, et al. Late clinical outcome in patients with early ventricular fibrillation after myocardial infarction. J Am Coll Cardiol. 1988;11:464–470
  9. Tofler GH, Stone PH, Muller JE, Rutherford JD, Willich SN, Gustafson NF, et al. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Am J Cardiol. 1987;60:755–761
  10. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris prospective study I. Circulation. 1999;99:1978–1983
  11. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction—results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol. 1998;82:265–271
  12. Ruiz-Bailen M, Aguayo D, Ruiz-Navarro S, Issa-Khozouz Z, Reina-Toral A, Diaz-Castellanos MA, et al. Ventricular fibrillation in acute myocardial infarction in Spanish patients: results of the ARIAM database. Crit Care Med. 2003;31:2144–2151
  13. Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, et al Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 2002;106:309–312
  14. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes (The GUSTO Investigators). Circulation. 1998;98:2567–2573
  15. Rahimi K, Watzlawek S, Thiele H, Secknus M-A, Hayerizadeh B-F, Niebauer J, et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non–ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J. 2006;27:1706–1711
  16. Sayer JW, Archbold RA, Wilkinson P, Ray S, Ranjadayalan K, Timmis AD. Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction. Heart. 2000;84:258–261
  17. Spencer FA, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 2001;142:594–603
  18. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 2000;343:385–391
  19. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, et al Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction (STOPAMI-2) Study (Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial). Lancet. 2002;359:920–925
  20. Harrington RA, Becker RC, Ezekowitz M, Meade TW, O'Connor CM, Vorchheimer DA, et al. Antithrombotic therapy for coronary artery disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl):513S–548S
  21. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction (Results of the survival and ventricular enlargement trial). N Engl J Med. 1992;327:669–677
  22. Barron HV, Bowlby LJ, Breen T, Rogers WJ, Canto JG, Zhang Y, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction. Circulation. 1998;97:1150–1156
  23. Go AS, Barron HV, Rundle AC, Ornato JP, Avins AL. Bundle-branch block and in-hospital mortality in acute myocardial infarction (National Registry of Myocardial Infarction 2 Investigators). Ann Intern Med. 1998;129:690–697
  24. Guerrero M, Harjai K, Stone GW, Brodie B, Cox D, Boura J, et al. Comparison of prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the Primary Angioplasty in Myocardial Infarction Trials. Am J Cardiol. 2005;96:482–488
  25. Gheeraert PJ, De Buyzere ML, Taeymans YM, Gillebert TC, Henriques JP, De Backer G, et al. Risk factors for ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2006;27:2499–2510
  26. Kyriakidis M, Petropoulakis P, Antopnopoulos A, Barbetseas J, Georgiakodis F, Aspiotis N, et al. Early ventricular fibrillation in patients with acute myocardial infarction: correlation with coronary angiographic findings. Eur Heart J. 1993;14:364–368
  27. Hajbaghery MA, Mousavi G, Akbari H. Factors influencing survival after in-hospital cardiopulmonary resuscitation. Resuscitation. 2005;66:317–321
  28. Chan PS, Krumholz HM, Nichol G, Nallamothu BK American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators. Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med. 2008;358:9–17
  29. Ewy GA, Ornato JP. 31st Bethesda Conference: emergency cardiac care—task force 1: cardiac arrest. J Am Coll Cardiol. 2000;35:832–846

 Funding support was provided by Grant RO1 HL35434 from the National Institutes of Health, Bethesda, Maryland.

PII: S0002-9149(08)01377-5

doi: 10.1016/j.amjcard.2008.08.008

American Journal of Cardiology
Volume 102, Issue 12 , Pages 1595-1601 , 15 December 2008

Article Tools

* Image Usage & Resolution